GGI

GordonMD Global Investments Portfolio holdings

AUM $144M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$144M
AUM Growth
+$4.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
16
New
Increased
Reduced
Closed

Top Buys

1
+$15.7M
2
+$5.94M
3
+$5.19M
4
VIR icon
Vir Biotechnology
VIR
+$4.69M
5
ALLO icon
Allogene Therapeutics
ALLO
+$2.87M

Top Sells

1
+$4.34M
2
+$2.76M
3
+$1.68M
4
KYTX icon
Kyverna Therapeutics
KYTX
+$1.22M
5
INCY icon
Incyte
INCY
+$1.12M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYTX icon
1
Kyverna Therapeutics
KYTX
$534M
$36.6M 25.51%
4,244,818
-147,000
TSHA icon
2
Taysha Gene Therapies
TSHA
$1.68B
$22.2M 15.47%
737,550
-593,351
VIR icon
3
Vir Biotechnology
VIR
$1.57B
$13.6M 9.48%
1,518,552
+588,235
BLCO icon
4
Bausch + Lomb
BLCO
$5.63B
$9.12M 6.35%
573,472
-40,000
AMGN icon
5
Amgen
AMGN
$184B
$7.11M 4.95%
20,212
-3,000
SRRK icon
6
Scholar Rock
SRRK
$6.08B
$6.51M 4.54%
+132,500
RARE icon
7
Ultragenyx Pharmaceutical
RARE
$2.29B
$6.06M 4.22%
289,101
-40,000
PYXS icon
8
Pyxis Oncology
PYXS
$109M
$6.02M 4.19%
4,121,870
TEVA icon
9
Teva Pharmaceuticals
TEVA
$40.7B
$5.62M 3.91%
1,257,495
+487,945
SION
10
Sionna Therapeutics
SION
$1.97B
$5.45M 3.8%
+136,000
CLDX icon
11
Celldex Therapeutics
CLDX
$2.5B
$5.4M 3.76%
170,307
INSM icon
12
Insmed
INSM
$23.3B
$4.67M 3.26%
28,587
CRNX icon
13
Crinetics Pharmaceuticals
CRNX
$3.8B
$4.61M 3.21%
126,985
-97,150
INCY icon
14
Incyte
INCY
$19.6B
$4.08M 2.84%
43,300
-11,200
ALLO icon
15
Allogene Therapeutics
ALLO
$773M
$3.49M 2.43%
+1,430,000
TARS icon
16
Tarsus Pharmaceuticals
TARS
$2.61B
$2.99M 2.09%
42,680
-24,000